RxDoctor Payments Data

Rachael Williams, MD

Surgery · West Hills, CANPI 1386887362

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by KCI USA, Inc. at 58.2% of the total. Reporting peaked in 2020 at $6,321 and has fallen 88.3% since, to $737 in 2025.

$12,282in general payments, 2019–2025

Across 132 payments — averaging $93.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$7K
  • Smith+Nephew$4K
  • Polynovo North America LLC$380
  • Avita Medical Americas, LLC$180
  • Sanara Medtech Inc.$164
  • Organogenesis Inc.$129
  • plus $404 from 5 others

What the payments were for

  • Consulting fees$5,03841%
  • Speaking & faculty fees$7506%
  • Travel & lodging$2,31919%
  • Food & beverage$4,17534%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,282 in reported general payments places this provider in the 80th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024
$84,610
Medicare patients
106
Services billed
1,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clindamycin Hcl19$137
NyamycNystatin12$112
Levofloxacin21$63
Doxycycline Hyclate21$57
Mupirocin16$34

Paid to pharmacies, not to this prescriber.

Other surgery in West Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →